MetaCap

Integra LifeSciences Earnings

NASDAQ: IARTHealth CareMedical/Dental InstrumentsUSD

13.44+0.03 (+0.22%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Next earnings date

Wed, Oct 21, 2026

Before market open

Fiscal period

Sep/2026

EPS estimate

$0.56

Integra LifeSciences earnings summary

Integra LifeSciences is scheduled to report Sep/2026 earnings on Oct 21, 2026 before the market opens, with analysts expecting EPS of $0.56. In its most recent report on Jul 29, 2026 (Q2 2026), IART posted EPS of $0.06. Revenue for the quarter was $418.8 million.

Across the last 16 reports, IART shares moved an average of 5.5% (in either direction) in the first trading session after results, rising 8 times and falling 8 times.

Summary generated from market data by MetaCap's automated system. Methodology

IART earnings history

Integra LifeSciences reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Jul 29, 2026—$0.06—+3.6%
May 5, 2026—$-0.06—+1.3%
Feb 26, 2026—$-0.03—-14.5%
Oct 30, 2025—$-0.07—+0.2%
Jul 31, 2025—$-6.31—+5.3%
May 5, 2025—$-0.33—+10.8%
Feb 25, 2025—$0.25—-0.9%
Nov 4, 2024—$-0.14—-7.7%
Jul 29, 2024—$-0.16—-9.3%
May 6, 2024—$-0.04—+6.0%
Feb 28, 2024—$0.26—+2.1%
Oct 25, 2023—$0.24—+13.3%
Jul 27, 2023—$0.05—-1.5%
Apr 26, 2023—$0.29—-8.3%
Feb 22, 2023—$0.63—-1.6%
Oct 26, 2022—$0.60—-2.2%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related